Feed MEDP
ME

Medpace MEDP NASDAQ · Healthcare · United States

$610.54 -3.70% -$23.44

Market cap
$17.7B
Enterprise value
$17.2B
P/E
34.2x
Forward P/E
33.2x
PEG
3.4x
P/S
6.2x
P/FCF
26.6x
EV/EBITDA
26.7x
ROIC
62.2%
Gross margin
29.1%
Net margin
18.2%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-0.9x
Beta
1.12
Free float
81.2%

About the company

Medpace Holdings, Inc. (MEDP) is a global company specializing in clinical research and the development of drugs and medical devices. With over twenty years of experience in the field, Medpace provides comprehensive clinical trial services for pharmaceutical and biotechnology companies. The company is known for its expertise, technological innovation, and commitment to ensuring high-quality and safe pharmaceutical products. Medpace Holdings, Inc. (MEDP) shares could be suitable for investors looking to invest in a company playing a key role in clinical research and the development of drugs and medical devices.

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

August James Troendle

Employees

6,600

Headquarters

Cincinnati

Valuation

Is today's price reasonable?

  • What to watch: The share price is above the Bulios Fair Price.

Growth and estimates

Is it growing, and what comes next?

  • What speaks for it: Earnings per share grew by 28% a year over the last 3 years.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: Out of every 100 USD of revenue, 18 USD is left as net profit.
  • What speaks for it: It earns 62 USD a year on every 100 USD of invested capital.

Financial health

Can it carry its debt?

  • What speaks for it: It holds more cash than debt: $705.3M against $146.0M.

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy